Literature DB >> 9119409

ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers.

E P Sulman1, X X Tang, C Allen, J A Biegel, D E Pleasure, G M Brodeur, N Ikegaki.   

Abstract

Mouse eck, a member of the EPH gene family, has been mapped to mouse chromosome 4. The syntenic relationship between this chromosome and human chromosome 1 suggests that the human ECK gene maps to the distal short arm of human chromosome 1 (1p). Since this region is frequently deleted or altered in certain tumors of neuroectodermal origin, it is important to define the specific chromosomal localization of the human ECK gene. PCR screening of a rodent-human somatic cell hybrid panel by ECK-specific primers showed that ECK is indeed localized to human chromosome 1. Additional PCR screening of a regional screening panel for chromosome 1p indicated that ECK is localized to 1p36, distal to FUCA1. Furthermore, fluorescence in situ hybridization analysis with an ECK-specific P1 clone showed that ECK maps proximal to genetic marker D1S228. Taken together, the data suggest that ECK maps to 1p36.1, a region that is frequently deleted in neuroblastoma, melanoma, and other neuroectodermal tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9119409     DOI: 10.1006/geno.1996.4569

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  32 in total

Review 1.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

Review 2.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

3.  Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.

Authors:  Yong Liu; Changyun Yu; Yuanzheng Qiu; Donghai Huang; Xiaojuan Zhou; Xin Zhang; Yongquan Tian
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-16       Impact factor: 4.553

Review 4.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

5.  EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxel.

Authors:  Pingqing Tan; Yong Liu; Changyun Yu; Zhongwu Su; Guo Li; Xiaojuan Zhou; Donghai Huang; Xin Zhang; Yuanzheng Qiu; Yongquan Tian
Journal:  Oncol Lett       Date:  2012-06-08       Impact factor: 2.967

6.  Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.

Authors:  Xia Li; Li Wang; Jian-Wen Gu; Bing Li; Wei-Ping Liu; Yan-Gang Wang; Xiang Zhang; Hai-Ning Zhen; Zhou Fei
Journal:  Tumour Biol       Date:  2010-06-23

7.  EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.

Authors:  Alexandra C Finney; Steven D Funk; Jonette M Green; Arif Yurdagul; Mohammad Atif Rana; Rebecca Pistorius; Miriam Henry; Andrew Yurochko; Christopher B Pattillo; James G Traylor; Jin Chen; Matthew D Woolard; Christopher G Kevil; A Wayne Orr
Journal:  Circulation       Date:  2017-05-09       Impact factor: 29.690

Review 8.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

9.  Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis.

Authors:  Weijie Yuan; Zhikang Chen; Shaobin Wu; Jie Ge; Shi Chang; Xianwei Wang; Jingxiang Chen; Zihua Chen
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

10.  EphA2 overexpression promotes ovarian cancer growth.

Authors:  Chunhua Lu; Mian M K Shahzad; Hua Wang; Charles N Landen; Seung W Kim; Julie Allen; Alpa M Nick; Nicholas Jennings; Michael S Kinch; Menashe Bar-Eli; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2008-04-19       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.